Siponimod versus placebo in secondary progressive multiple s…
Siponimod versus placebo in secondary progressive multiple sclerosis %2525252528EXPAND%2525252529%252525253A a double-blind%252525252C randomized%252525252C phase 3 study
Article, Chapter
Full text availability for this item
Journal:
Lancet, TheOpens in new Window
Coverage:
- 1823-10-05~present; volume:1~present;issue:1~present